External quality assessment scheme for influenza virus detection, isolation and culture for the European Reference Laboratory Network for Human Influenza, 2013
In September/October 2013, the European Reference Laboratory Network for Human Influenza (ERLI-Net) conducted an external quality assessment (EQA) for the rapid detection of influenza virus, its isolation and culture.
Handbook on tuberculosis laboratory diagnostic methods in the European Union - Updated 2018
This handbook provides network members and other laboratories involved in the diagnosis of tuberculosis, with an agreed list of key diagnostic methods and their protocols in various areas of TB diagnosis.
European Reference Laboratory Network for Human Influenza (ERLI-Net)
The ERLI-Net sub-network of reference laboratories of the European Influenza Surveillance Network carries out virological surveillance of human influenza in the EU/EEA through the EISN timely reporting mechanism and strengthening laboratory capacity for influenza virus detection, antiviral susceptibility testing and typing.
About the network
The main objectives of ERLI-Net are to carry out virological surveillance of human influenza and to ensure that data are shared through the European Influenza Surveillance Network (EISN) reporting mechanisms in a timely manner.
Influenza laboratory quality control
In accordance with the Key Tasks, ERLI-Net laboratories should participate in external quality assurance (EQA) schemes. EQA panels are distributed by both ERLI-Net and the WHO.
WHO global web-based tool for influenza virological surveillance (FluNet)
FluNet is a global web-based tool for influenza virological surveillance. The number of influenza viruses detected by subtype are critical for tracking the movement of viruses globally and interpreting the epidemiological data. The data at country level are publically available and updated weekly. The results are presented in various formats including tables, maps and graphs.
Laboratory readiness and response for novel coronavirus (2019-nCoV) in expert laboratories in 30 EU/EEA countries, January 2020
A first assessment looking at the preparedness of EU/EEA laboratories to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) demonstrates a fast implementation of molecular diagnostics by the European specialised laboratory networks. It also shows a good geographical coverage for testing.
First Worldwide Proficiency Study on Variable-Number Tandem-Repeat Typing of Mycobacterium tuberculosis Complex Strains
de Beer, J.L., Kremerb, K., Ködmön, C., Supplyd, P., van Soolingen, D., the Global Network for the Molecular Surveillance of Tuberculosis, 2009
Guidance for clinical and public health laboratories testing for influenza virus antiviral drug susceptibility in Europe
Pozo, F., Lina, B., Andrade, H.R., Enouf, V., Kossyvakis, A., Broberg, E., Daniels, R., Lackenby, A., Meijer, A.